http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-045509-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_173bc2c63b34988699010ba05e5b1376
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-01
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90
filingDate 2004-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-045509-A1
titleOfInvention AVERMECTINES AND MONOSACARIDS OF SUBSTITUTED FINDINGS IN POSITION 4 'AND 4'ยด THAT HAVE PESTICIDED PROPERTIES
abstract Claim 1: A compound of the formula (1) in which the bond between the atoms of C22 and 23 is a single or double bond: m is 0 or 1; R1 is C1-12 alkyl, C3-8 cycloalkyl or C2-12 alkenyl; and either (A) R2 is -N (R3) R4, and (1) X is O, wherein R3 is H, unsubstituted C1-12 alkyl or mono-substituted pentas, unsubstituted C3-12 cycloalkyl or mono- a pentasubstituted, unsubstituted C2-12 alkenyl or mono- to pentasubstituted, unsubstituted C2-12 alkynyl or mono- to pentasubstituted, aryl or heterocyclyl and R4 is C1-12 alkyl mono to pentasubstituted, C3-12 cycloalkyl unsubstituted or mono- a pentasubstituted, unsubstituted C2-12 alkenyl or mono- to pentasubstituted, unsubstituted C2-12 alkynyl or mono- to pentasubstituted, unsubstituted or mono- to trisubstituted heterocyclyl, unsubstituted aryl or mono- to pentasubstituted, NH2; NH C1-12 alkyl, N (C1-12 alkyl) 2, -C1-6 alkyl-N (C1-12 alkyl) 2, -C1-6 alkyl-N (C1-12 alkyl) 3, SO2NH2, SO2NHC6H5, SO2phenyl, SO 2 benzyl, OH, -O-C 1-12 alkyl, -C 1-12 alkenyl or -C 1-12 alkynyl; or (2) X is S, wherein R3 is H, unsubstituted C1-12 alkyl or mono-penta substituted, unsubstituted or mono-substituted C3-12 cycloalkyl, unsubstituted C2-12 alkenyl or mono-substituted pentas, alkynyl C2-12 unsubstituted or mono-penta substituted; aryl or heterocyclyl; and R4 is H, unsubstituted or mono-substituted C1-12 alkyl, unsubstituted or mono-substituted C3-12 cycloalkyl, unsubstituted C2-12 alkenyl or mono-substituted penta, unsubstituted C2-12 alkynyl or mono-a pentasubstituted; unsubstituted heterocyclyl and mono- to trisubstituted, unsubstituted aryl and mono- to pentasubstituted, NH2, NH12-12 alkyl, N (C1-12 alkyl) 2, SO2NH2, SO2NHC6H5, SO2phenyl, SO2benzyl, OH, or -O-C1 alkyl -12; or (3) X 3 is O or S, where R3 and R4 together are a 3 to 7 member alkylene bridge or a 4 to 7 member alkylene, where a CH2 group can be replaced with O, S, C = O or NR6; or (B) R2 is OR5 and X is O or S, wherein R5 is C1-12 alkyl, C1-2 alkyl mono- to pentasubstituted, C3-12 cycloalkyl unsubstituted or mono- to pentasubstituted, C2-12 alkenyl or mono-to penta substituted, unsubstituted C2-12 alkynyl or mono-to penta substituted; wherein the substituents of the alkyl, alkenyl, alkynyl, alkylene, alkenylene, heterocyclyl, aryl and cycloalkyl radicals mentioned under R3, R4 and R5 are selected from the group consisting of OH, halogen, C1-12 haloalkyl, CN, SCN, NO2, C2-6 alkynyl, C3-8 cycloalkyl which is unsubstituted or substituted with one or three methyl groups, norbornylenyl; C3-8 cycloalkenyl which is unsubstituted or substituted with one to three methyl groups, C3-8 heterocycloalkyl, C1-12 alkoxy, C1-12 alkoxy-C1-12 alkoxy, C3-8 cycloalkoxy, C1-12 alkylthio, C3 cycloalkylthio -8, C1-12 haloalkylthio, C1-12 alkylsulfinyl, C3-8 cycloalkylsulfinyl, C1-12 haloalkylsulfinyl, C3-8 halocycloalkylsulfinyl, C1-12 alkylsulfonyl, C3-8 cycloalkylsulfonyl, C1-12 haloalkylsulfonyl, C3- C2- alkylsulfonyl -8, C2-8 alkynyl, -N (R6) 2, wherein the two R6 are independent of each other; -C (= O) R7, -OC (= O) R8, -NHC (= O) R7, -SC (= S) R8, -P (= O) (C1-6 alkyl) 2, -S (= O) 2R11; -NH-S (= O) 2R11, -OC (= O) -C 1-6 alkyl-S (= O) 2R11; aryl, benzyl, heterocyclyl, aryloxy, benzyloxy, heterocyclyloxy, arylthio, benzylthio, heterocyclyl; and also aryl, heterocyclyl, aryloxy, benzyloxy, heterocyclyloxy, arylthio, benzylthio or heterocyclyl which, depending on the possibilities of ring substitution, are mono-to penta substituted with substituents selected from the group consisting of OH, halogen, CN, NO2, C1-12 alkyl, C3-8 cycloalkyl, C1-12 haloalkyl, C1-12 alkoxy, C1-12 haloalkoxy, C1-12 alkylthio, C1-12 haloalkyl, C1-6 alkoxy-C1-6 alkyl, dimethylamino-C1-alkoxy 6, C2-8 alkenyl, C2-8 alkynyl, phenoxy, phenylC 1-6 alkyl, methylenedioxy, -C (= O) R7; -OC (= O) -R8, -NH-C (= O) R8-, -N (R10) 2, where the two R10 are independent of each other, C1-6 alkylsulfinyl, C3-8 cycloalkylsulfinyl, C1- haloalkylsulfinyl 6, C 3-8 halocycloalkylsulfinyl, C 1-6 alkylsulfonyl, C 3-8 cycloalkylsulfonyl, C 1-6 haloalkylsulfonyl and C 3-8 halocycloalkylsulfonyl; R6 is h, C1-8 alkyl, hydroxy-C1-8 alkyl, C3-8 cycloalkyl, C2-8 alkenyl, C2-8 alkynyl, phenyl, benzyl, -C (= O) R7 or -CH2-C (= O ) -R7; R7 is H, OH, SH, -N (R10) 2, where the two R10 are independent of each other; C1-24 alkyl, C2-12 alkenyl, C1-8 hydroxyalkyl, C1-12 haloalkyl, C1-12 alkoxy, halo C1-12 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1- alkoxy 6, C1-6 alkoxy-C1-6 alkoxy-C1-6 alkyl, C1-12 alkylthio, C2-8 alkenyloxy, C2-8 alkynyloxy, NH-C1-6-C alkyl - (= O) R9, -N ( C1-6 alkyl) -C 1-6 alkyl (= O) -R9, -O-C1-2-C alkyl (= O) R9, -C 1-6 alkyl-S (= O) 2R9, aryl, benzyl, heterocyclyl , aryloxy, benzyloxy, heterocyclyloxy, or aryl, benzyl, heterocyclyl, aryloxy, benzyloxy or heterocyclyloxy, which are unsubstituted or mono-a trisubstituted in the ring independently of each other with halogen, nitro, C1-6 alkyl, C1-6 alkoxy C1-6 haloalkyl or C1-6 haloalkoxy ;; R8 is H, C1-12 alkyl, C1-12 haloalkyl, C1-12 hydroxyalkyl, C2-8 alkenyl, C2-8 alkynyl, C1-6 alkoxy-C1-6 alkyl, N (R10) 2, wherein the two r10 they are independent of each other; -C1-6-C alkyl (= O) R10, -C1-6-S alkyl (= O) 2R9, aryl, benzyl, heterocyclyl, or aryl, benzyl or heterocyclyl which, depending on the possibilities of ring substitution , the group consisting of OH, halogen, CN, NO2, C1-12 alkyl, C1-12 haloalkyl, C1-12 alkoxy, C1-12 haloalkoxy, C1-12 alkylthio and C1-12 haloalkylthio are mono- to trisubstituted with substituents selected ; R9 is H, OH, C1-24 alkyl which is optionally substituted with OH, or -S (= O) 2-C1-6 alkyl; C1-12 alkenyl, C1-12 alkynyl, C1-12 alkoxy. C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkoxy, C2-8 alkenyloxy, aryl, aryloxy, benzyloxy, heterocyclyl, heterocyclyloxy or -N (R10) 2, wherein the two R10 are independent of yes; R10 is H, C1-6 alkyl, which is optionally substituted with one to five substituents selected from the group consisting of halogen, C1-6 alkoxy, hydroxy and cyano; C1-8 cycloalkyl, aryl, benzyl, heterocyclyl; or aryl, benzyl or heterocyclyl, which, depending on the possibilities of substitution in the ring, are mono- to trisubstituted with substituents selected from the group consisting of OH, halogen, CN, NO2, C1-12 alkyl, C1-12 haloalkyl, C1-12 alkoxy, C1-12 haloalkoxy, C1-12 alkylthio and C1-12 haloalkylthio; or, if appropriate, an E / Z isomer, mixture of E / Z isomers and / or tautomers thereof, in each case in free form or in salt form.
priorityDate 2003-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834

Total number of triples: 20.